Patients are affected by retained blood3
Reliable Drainage
Without Exception
CirculaTech is developing proprietary medical technology
intended to improve the reliability of postoperative drainage
in cardiothoracic care.
CLINICAL NEED
Retained Blood
in the chest, following cardiothoracic surgery is attributed to incomplete drainage caused by clogged surgical drains. This undrained blood leads to increased morbidity, mortality, and length of stay of patients.1,3
CirculaTech is addressing this need by developing a self-irrigating surgical drain designed to proactively maintain patency and improve the reliability of postoperative drainage.
References
- Karimov JH, Gillinov AM, Schenck L, et al. Incidence of chest tube clogging after cardiac surgery: a single-centre prospective observational study. Eur J Cardiothorac Surg. 2013;44(6):1029–1036.
- Thomas N. Retained Blood Syndrome and 90-day care costs. Dexur.
- Balzer F, von Heymann C, Boyle EM, et al. Impact of retained blood requiring reintervention on outcomes after cardiac surgery. J Thorac Cardiovasc Surg. 2016;152(2):595–601.e4.
- Tauriainen T, Kinnunen EM, Koski-Vähälä J, et al. Outcome after procedures for retained blood syndrome in coronary surgery. Eur J Cardiothorac Surg. 2017;51(6):1078–1085.
- Gerdisch MW, Johns C, Parikshak M, Barksdale A, Perrault LP. Active Chest Tube Clearance Added to an Enhanced Recovery After Cardiac Surgery (ERAS) Program Improves Outcomes and Reduces Resource Utilization. Innovations (Phila). 2025;20(2):194–200.
Supported by Leading Institutions
We are proud to collaborate with world-class organizations across healthcare,
research, and innovation.
Founding Team & Advisory Board
Founder & CEO
Clinical & Technical Advisory
Glenn Egrie MD
Clinical
Cardiothoracic Surgeon,
Sutter Health
Chris Ross
R&D
President,
Engineering Resources Group
Jack Griffis
Manufacturing
CTO, Kessel Medical
Commercial & Strategic Advisory
Maxim Budyansky
Full Product Lifecycle /
Sales / Commercialization
Exited Founder & Investor
Ward Broom
Bis Dev &
Commercialization
Exited Founder & Investor

